3M 55045 Superfast Plastic Adhesive (Part A)

Hazard statements (CLP)

H315, H317, H319, H331, H334, H335, H351, H373

Code

Statements

H315

Causes skin irritation

SECTION 2: Hazards identification

Regulation (EC) No. 1272/2008 Classification of the substance or mixture

Hazard pictograms

GHS06 (Skull and crossbones) |GHS08 (Health Hazard) | Ingredients: Ingredient CAS Nbr EC No. % by Wt 4,4’-Methylenediphenyl diisocyanate, oligomers 500-040-3 45 - 85 Isocyanic Acid, 3-(Triethoxysilyl)Propyl Ester 24801-88-5 246-467-6 0.1 - 1

Hazard statements

H331 Toxic if inhaled. H315 Causes skin irritation. H319 Causes serious eye irritation. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H317 May cause an allergic skin reaction. H351 Suspected of causing cancer. H335 May cause respiratory irritation. H373 May cause damage to organs through prolonged or repeated exposure: respiratory system.

Prevention

P261A Avoid breathing vapours. P280E Wear protective gloves. P261A Avoid breathing vapours. P280E Wear protective gloves.

Response

P304 + P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P333 + P313 If skin irritation or rash occurs: Get medical advice/attention. P342 + P311 If experiencing respiratory symptoms: Call a POISON CENTRE or doctor/physician. P304 + P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P333 + P313 If skin irritation or rash occurs: Get medical advice/attention. P342 + P311 If experiencing respiratory symptoms: Call a POISON CENTRE or doctor/physician.

Storage

P403 + P233 Store in a well-ventilated place. Keep container tightly closed. For containers not exceeding 125 ml the following Hazard and Precautionary statements may be used: <=125 ml Hazard statements H331 Toxic if inhaled. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H317 May cause an allergic skin reaction. H351 Suspected of causing cancer. <=125 ml Precautionary statements P403 + P233 Store in a well-ventilated place. Keep container tightly closed. 39% of the mixture consists of components of unknown acute oral toxicity.

Contains

39% of components with unknown hazards to the aquatic environment Information required per Regulation (EU) 2020/1149 as regards diisocyanates: As from 24 August 2023 adequate training is required before industrial or professional use. Further information can be found at feica.eu/Puinfo

2.3 Other hazards

Persons previously sensitised to isocyanates may develop a cross-sensitisation reaction to other isocyanates. This material does not contain any substances that are assessed to be a PBT or vPvB

2.1 Classification of the substance or mixture

CLP REGULATION (EC) No 1272/2008 The health and environmental classifications of this material have been derived using the calculation method, except in cases where test data are available or the physical form impacts classification. Classification(s) based on test data or physical form are noted below, if applicable. CLASSIFICATION: Acute Toxicity, Category 3 - Acute Tox. 3; H331 Skin Corrosion/Irritation, Category 2 - Skin Irrit. 2; H315 Serious Eye Damage/Eye Irritation, Category 2 - Eye Irrit. 2; H319 Respiratory Sensitization, Category 1 - Resp. Sens. 1; H334 Skin Sensitization, Category 1 - Skin Sens. 1; H317 Carcinogenicity, Category 2 - Carc. 2; H351 Specific Target Organ Toxicity-Repeated Exposure, Category 2 - STOT RE 2; H373 Specific Target Organ Toxicity-Single Exposure, Category 3 - STOT SE 3; H335 For full text of H phrases, see Section 16. 2.2. Label elements CLP REGULATION (EC) No 1272/2008 SIGNAL WORD DANGER. Symbols GHS06 (Skull and crossbones) |GHS08 (Health Hazard) | Pictograms Ingredients: Ingredient CAS Nbr EC No. % by Wt 4,4’-Methylenediphenyl diisocyanate, oligomers 500-040-3 45 - 85 Isocyanic Acid, 3-(Triethoxysilyl)Propyl Ester 24801-88-5 246-467-6 0.1 - 1 HAZARD STATEMENTS: H331 Toxic if inhaled. H315 Causes skin irritation. H319 Causes serious eye irritation. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H317 May cause an allergic skin reaction. H351 Suspected of causing cancer. H335 May cause respiratory irritation. H373 May cause damage to organs through prolonged or repeated exposure: respiratory system. PRECAUTIONARY STATEMENTS Prevention: P261A Avoid breathing vapours. P280E Wear protective gloves. Response: P304 + P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P333 + P313 If skin irritation or rash occurs: Get medical advice/attention. P342 + P311 If experiencing respiratory symptoms: Call a POISON CENTRE or doctor/physician. Storage: P403 + P233 Store in a well-ventilated place. Keep container tightly closed. For containers not exceeding 125 ml the following Hazard and Precautionary statements may be used: <=125 ml Hazard statements H331 Toxic if inhaled. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H317 May cause an allergic skin reaction. H351 Suspected of causing cancer. <=125 ml Precautionary statements Prevention: P261A Avoid breathing vapours. P280E Wear protective gloves. Response: P304 + P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P333 + P313 If skin irritation or rash occurs: Get medical advice/attention. P342 + P311 If experiencing respiratory symptoms: Call a POISON CENTRE or doctor/physician. Storage: P403 + P233 Store in a well-ventilated place. Keep container tightly closed. 39% of the mixture consists of components of unknown acute oral toxicity. Contains 39% of components with unknown hazards to the aquatic environment. Information required per Regulation (EU) 2020/1149 as regards diisocyanates: As from 24 August 2023 adequate training is required before industrial or professional use. Further information can be found at feica.eu/Puinfo 2.3. Other hazards Persons previously sensitised to isocyanates may develop a cross-sensitisation reaction to other isocyanates. This material does not contain any substances that are assessed to be a PBT or vPvB SECTION 3: Composition/information on ingredients 3.1. Substances Not applicable 3.2. Mixtures Ingredient Identifier(s) % Classification according to Regulation (EC) No. 1272/2008 [CLP] 4,4’-Methylenediphenyl diisocyanate, (EC-No.) 500-040-3 45 - 85 Carc. 2, H351 oligomers Acute Tox. 4, H332 Skin Irrit. 2, H315 Eye Irrit. 2, H319 Resp. Sens. 1, H334 Skin Sens. 1, H317 STOT SE 3, H335 STOT RE 2, H373 Castor Oil, Polymer With 1,1'- (CAS-No.) 68424-09-9 15 - 40 Substance with a national occupational Methylenebis[4-Isocyanatobenzene] exposure limit [3-(2,3- (CAS-No.) 2530-83-8 1 - 5 Eye Dam. 1, H318 epoxypropoxy)propyl]trimethoxysilane (EC-No.) 219-784-2 Aquatic Chronic 3, H412 (REACH-No.) 01- 2119513212-58 Isocyanic Acid, 3-(Triethoxysilyl)Propyl (CAS-No.) 24801-88-5 0.1 - 1 Acute Tox. 1, H330 Ester (EC-No.) 246-467-6 Acute Tox. 4, H312 Acute Tox. 4, H302 Skin Corr. 1B, H314 Resp. Sens. 1, H334 Skin Sens. 1, H317 Please see section 16 for the full text of any H statements referred to in this section Specific Concentration Limits Ingredient Identifier(s) Specific Concentration Limits 4,4’-Methylenediphenyl diisocyanate, (EC-No.) 500-040-3 (C >= 5%) Skin Irrit. 2, H315 oligomers (C >= 5%) Eye Irrit. 2, H319 (C >= 0.1%) Resp. Sens. 1, H334 (C >= 5%) STOT SE 3, H335 For information on ingredient occupational exposure limits or PBT or vPvB status, see sections 8 and 12 of this SDS SECTION 4: First aid measures 4.1. Description of first aid measures Inhalation Remove person to fresh air. If you feel unwell, get medical attention. Skin contact Immediately wash with soap and water. Remove contaminated clothing and wash before reuse. If signs/symptoms develop, get medical attention. Eye contact Immediately flush with large amounts of water. Remove contact lenses if easy to do. Continue rinsing. Get medical attention. If swallowed Rinse mouth. If you feel unwell, get medical attention. 4.2. Most important symptoms and effects, both acute and delayed The most important symptoms and effects based on the CLP classification include: Toxic if inhaled. Irritating to the respiratory tract (coughing, sneezing, nasal discharge, headache, hoarseness, and nose and